{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:16:42Z","timestamp":1788491802165,"version":"build-2803163510"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,1,1]]},"DOI":"10.1093\/humrep\/dei290","type":"journal-article","created":{"date-parts":[[2005,9,22]],"date-time":"2005-09-22T00:13:43Z","timestamp":1127348023000},"page":"248-256","source":"Crossref","is-referenced-by-count":158,"title":["Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain"],"prefix":"10.1093","volume":"21","author":[{"given":"P.G.","family":"Crosignani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Luciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bergqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,9,21]]},"reference":[{"key":"key\n\t\t\t\t20171012082621_AILAWADI-ET-AL-2004","doi-asserted-by":"crossref","unstructured":"Ailawadi RK , Jobanputra S, Kataria M, Gurates B and Bulun SE (2004) Treatment of endometriosis and chronic pelvic pain with letrozole and no-rethindrone acetate: a pilot study. Fertil Steril81,290\u2013296.","DOI":"10.1016\/j.fertnstert.2003.09.029"},{"key":"key\n\t\t\t\t20171012082621_BERGQVIST-AND-THEORELL-2001","doi-asserted-by":"crossref","unstructured":"Bergqvist A and Theorell T (2001) Changes in quality of life after hormonal treatment of endometriosis. Acta Obstet Gynecol Scand80,628\u2013637.","DOI":"10.1080\/j.1600-0412.2001.800708.x"},{"key":"key\n\t\t\t\t20171012082621_BIBEROGLU-AND-BEHRMAN-1981","doi-asserted-by":"crossref","unstructured":"Biberoglu KO and Behrman SJ (1981) Dosage aspects of danazol therapy in endometriosis: short-term and long-term effectiveness. Am J Obstet Gynecol139,645\u2013654.","DOI":"10.1016\/0002-9378(81)90478-6"},{"key":"key\n\t\t\t\t20171012082621_BULUN-ET-AL-1999","doi-asserted-by":"crossref","unstructured":"Bulun SE , Zeitoun K, Takayama K, Noble L, Michael D, Simpson E, Johns A, Putman M and Sasano H (1999) Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis. Endocr Relat Cancer6,293\u2013301.","DOI":"10.1677\/erc.0.0060293"},{"key":"key\n\t\t\t\t20171012082621_BULUN-ET-AL-2004","doi-asserted-by":"crossref","unstructured":"Bulun SE , Fang Z, Imir G, Gurates B, Tamura M, Yilmaz B, Langoi D, Amin S, Yang S and Deb S (2004) Aromatase and endometriosis. Semin Reprod Med22,45\u201350.","DOI":"10.1055\/s-2004-823026"},{"key":"key\n\t\t\t\t20171012082621_CHILD-AND-TAN-2001","doi-asserted-by":"crossref","unstructured":"Child TJ and Tan SL (2001) Endometriosis: aetiology, pathogenesis and treatment. Drugs61,1735\u20131750.","DOI":"10.2165\/00003495-200161120-00005"},{"key":"key\n\t\t\t\t20171012082621_CGHFBC-1996","doi-asserted-by":"crossref","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer (1996) Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet347,1713\u20131727.","DOI":"10.1016\/S0140-6736(96)90806-5"},{"key":"key\n\t\t\t\t20171012082621_DLUGI-ET-AL-1990","doi-asserted-by":"crossref","unstructured":"Dlugi AM , Miller JD, Knittle J and the Lupron Study Group (1990) Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study. Fertil Steril54,419\u2013427.","DOI":"10.1016\/S0015-0282(16)53755-8"},{"key":"key\n\t\t\t\t20171012082621_ESKENAZI-AND-WARNER-1997","doi-asserted-by":"crossref","unstructured":"Eskenazi B and Warner ML (1997) Epidemiology of endometriosis. Obstet Gynecol Clin North Am24,235\u2013258.","DOI":"10.1016\/S0889-8545(05)70302-8"},{"key":"key\n\t\t\t\t20171012082621_HARRISON-AND-BARRY-KINSELLA-2000","doi-asserted-by":"crossref","unstructured":"Harrison RF and Barry-Kinsella C (2000) Efficacy of medroxyprogesterone treatment in infertile women with endometriosis: a prospective, randomized, placebo-controlled study. Fertil Steril74,24\u201330.","DOI":"10.1016\/S0015-0282(00)00577-X"},{"key":"key\n\t\t\t\t20171012082621_HORNSTEIN-ET-AL-1997","doi-asserted-by":"crossref","unstructured":"Hornstein MD , Hemmings R, Yuzpe AA and Heinrichs WL (1997) Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis. Fertil Steril68,860\u2013864.","DOI":"10.1016\/S0015-0282(97)00360-9"},{"key":"key\n\t\t\t\t20171012082621_JAIN-ET-AL-2004A","doi-asserted-by":"crossref","unstructured":"Jain J , Dutton C, Nicosia AF, Wajszczuk C, Bode FR and Mishell DR (2004) Pharmacokinetics, ovulation suppression, and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera\u00ae. Contraception70,11\u201318.","DOI":"10.1016\/j.contraception.2004.01.011"},{"key":"key\n\t\t\t\t20171012082621_JAIN-ET-AL-2004B","doi-asserted-by":"crossref","unstructured":"Jain J , Jakimiuk AJ, Bode FR, Ross D and Kaunitz AM (2004) Contraceptive efficacy and safety of DMPA-SC. Contraception70,269\u2013275.","DOI":"10.1016\/j.contraception.2004.06.011"},{"key":"key\n\t\t\t\t20171012082621_JAKIMIUK-2004","unstructured":"Jakimiuk A (2004) A new highly effective subcutaneous contraceptive injection [abstract]. Presented at the 8th Congress of the European Society of Contraception. Edinburgh, UK, June 23\u201326, 2004."},{"key":"key\n\t\t\t\t20171012082621_JONES-ET-AL-2002","doi-asserted-by":"crossref","unstructured":"Jones GL , Kennedy SH and Jenkinson C (2002) Health-related quality of life measurement in women with common benign gynecologic conditions: a systematic review. Am J Obstet Gynecol187,501\u2013511.","DOI":"10.1067\/mob.2002.124940"},{"key":"key\n\t\t\t\t20171012082621_KAUNITZ-2000","doi-asserted-by":"crossref","unstructured":"Kaunitz AM (2000) Injectable contraception: new and existing options. Obstet Gynecol Clin North Am27,741\u2013780.","DOI":"10.1016\/S0889-8545(05)70171-6"},{"key":"key\n\t\t\t\t20171012082621_KAUNITZ-AND-KIPERSZTOK-2005","unstructured":"Kaunitz AM and Kipersztok S (2005) Effect of DMPA-SC 104 and DMPA-IM on bone mineral density after up to 2 years of treatment. Poster presented at: Controversies in Obstetrics, Gynecology, and Infertility. Athens, Greece, April 14\u201317, 2005. Poster P05."},{"key":"key\n\t\t\t\t20171012082621_KAUNITZ-AND-MONTGOMERYRICE-2005","unstructured":"Kaunitz AM and Montgomery Rice V (2005) Recovery of total hip bone mineral density following discontinuation of DMPA-IM 150 mg\/mL contraceptive injection. Poster presented at the 12th World Congress of the International Academy of Human Reproduction. Venice, Italy, March 10\u201313, 2005. Poster 35."},{"key":"key\n\t\t\t\t20171012082621_KENNEDY-ET-AL-2005","doi-asserted-by":"crossref","unstructured":"Kennedy S , Bergqvist A, Chapron C, D\u2019Hooghe T, Dunselman G, Greb R, Hummelshoj L, Prentice A and Saridogan E (2005) ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod [Epub, June 24, ahead of print].","DOI":"10.1093\/humrep\/dei135"},{"key":"key\n\t\t\t\t20171012082621_KOCH-AND-GANSKY-1996","doi-asserted-by":"crossref","unstructured":"Koch GG and Gansky SA (1996) Statistical considerations for multiplicity in confirmatory protocols. Drug Inf J30,523\u2013534.","DOI":"10.1177\/009286159603000228"},{"key":"key\n\t\t\t\t20171012082621_KUPPERMAN-ET-AL-1953","doi-asserted-by":"crossref","unstructured":"Kupperman HS , Blatt MHG, Wiesbader H and Filler W (1953) Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices. J Clin Endocrinol Metab13,688\u2013703.","DOI":"10.1210\/jcem-13-6-688"},{"key":"key\n\t\t\t\t20171012082621_LUPRON-2004","unstructured":"Lupron Depot [package insert] (2004) Tap Pharmaceuticals. Lake Forest, III."},{"key":"key\n\t\t\t\t20171012082621_MARQUES-ET-AL-2004","unstructured":"Marques A , Bahamondes L, Aldrighi JM and Petta CA (2004) Quality of life in Brazilian women with endometriosis assessed through a medical outcome questionnaire. J Reprod Med49,115\u2013120."},{"key":"key\n\t\t\t\t20171012082621_MONTGOMERY-AND-KAUNITZ-2005","unstructured":"Montgomery Rice V and Kaunitz AM (2005) Evaluation of T-scores during use and following discontinuation of intramuscular depot medroxyprogesterone acetate 150 mg\/mL contraceptive injection. Poster presented at: 12th World Congress of the International Academy of Human Reproduction, Venice, Italy, March 10\u201313."},{"key":"key\n\t\t\t\t20171012082621_PELKMAN-2002","unstructured":"Pelkman C (2002) Hormones and weight change. J Reprod Med47,791\u2013794."},{"key":"key\n\t\t\t\t20171012082621_PELKMAN-ET-AL-2001","doi-asserted-by":"crossref","unstructured":"Pelkman CL , Chow M, Heinbach RA and Rolls BJ (2001) Short-term effects of a progestational contraceptive drug on food intake, resting energy expenditure, and body weight in young women. Am J Clin Nutr73,19\u201326.","DOI":"10.1093\/ajcn\/73.1.19"},{"key":"key\n\t\t\t\t20171012082621_RICE-2002","doi-asserted-by":"crossref","unstructured":"Rice VM (2002) Conventional medical therapies for endometriosis. Ann NY Acad Sci955,343\u2013352.","DOI":"10.1111\/j.1749-6632.2002.tb02795.x"},{"key":"key\n\t\t\t\t20171012082621_ROTONDI-ET-AL-2002","unstructured":"Rotondi M , Labriola D, Rotondi M, Ammaturo FP, Amato G, Carella C, Izzo A and Panariello S (2002) Depot leuprorelin acetate versus danazol in the treatment of infertile women with symptomatic endometriosis. Eur J Gynaecol Oncol23,523\u2013526."},{"key":"key\n\t\t\t\t20171012082621_SAITO-ET-AL-2003","unstructured":"Saito T , Yoshizawa M, Yamauchi Y, Kinoshita S, Fujii T, Mieda M, Sone H, Yamamoto Y and Koizumi N (2003) Effects of the novel orally active antiestrogen TZE-5323 on experimental endometriosis. Arzneimittel-Forschung53,507\u2013514."},{"key":"key\n\t\t\t\t20171012082621_SCHOLES-ET-AL-2002","doi-asserted-by":"crossref","unstructured":"Scholes D , LaCroix AZ, Ichikawa LE, Barlow WE and Ott SM (2002) Injectable hormone contraception and bone density: results from a prospective study. Epidemiology13,581\u2013587.","DOI":"10.1097\/00001648-200209000-00015"},{"key":"key\n\t\t\t\t20171012082621_SCHOLES-ET-AL-2005","doi-asserted-by":"crossref","unstructured":"Scholes D , LaCroix AZ, Ichikawa LE, Barlow WE and Ott SM (2005) Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception. Arch Pediatr Adolesc Med159,139\u2013144.","DOI":"10.1001\/archpedi.159.2.139"},{"key":"key\n\t\t\t\t20171012082621_SCHWEPPE-2001","doi-asserted-by":"crossref","unstructured":"Schweppe K-W (2001) Current place of progestins in the treatment of endometriosis-related complaints. Gynecol Endocrinol15 (Suppl 6),22\u201328.","DOI":"10.1080\/gye.15.s6.22.28"},{"key":"key\n\t\t\t\t20171012082621_SHAW-2003","doi-asserted-by":"crossref","unstructured":"Shaw RW (2003) Evaluation of the role of laser treatment for the treatment of pain in endometriosis. Ann NY Acad Sci997,240\u2013246.","DOI":"10.1196\/annals.1290.027"},{"key":"key\n\t\t\t\t20171012082621_STAGER-AND-CROMER-2000","doi-asserted-by":"crossref","unstructured":"Stager MM and Cromer BA (2000) Management of clinical side effects of DMPA. J Pediatr Adolesc Gynecol13,147\u2013149.","DOI":"10.1016\/S1083-3188(00)00054-1"},{"key":"key\n\t\t\t\t20171012082621_SUTTON-ET-AL-1994","doi-asserted-by":"crossref","unstructured":"Sutton CJG , Ewen SP, Whitelaw N and Haines P (1994) Prospective, randomized, double-blind, controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild, and moderate endometriosis. Fertil Steril62,696\u2013700.","DOI":"10.1016\/S0015-0282(16)56990-8"},{"key":"key\n\t\t\t\t20171012082621_TAKAYAMA-ET-AL-1998","doi-asserted-by":"crossref","unstructured":"Takayama K , Zeitoun K, Gunby RT, Sasano H, Carr BR and Bulun SE (1998) Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. Fertil Steril69,709\u2013713.","DOI":"10.1016\/S0015-0282(98)00022-3"},{"key":"key\n\t\t\t\t20171012082621_VALLE-AND-SCIARRA-2003","doi-asserted-by":"crossref","unstructured":"Valle RF and Sciarra JJ (2003) Endometriosis: treatment strategies. Ann NY Acad Sci997,229\u2013239.","DOI":"10.1196\/annals.1290.026"},{"key":"key\n\t\t\t\t20171012082621_VERCELLINI-ET-AL-1996","doi-asserted-by":"crossref","unstructured":"Vercellini P , De Giorgi O, Oldani S, Cortesi I, Panazza S and Crosignani PG (1996) Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis. Am J Obstet Gynecol175,396\u2013401.","DOI":"10.1016\/S0002-9378(96)70152-7"},{"key":"key\n\t\t\t\t20171012082621_VERCELLINI-ET-AL-1997","doi-asserted-by":"crossref","unstructured":"Vercellini P , Cortesi I and Crosignani PG (1997) Progestins for symptomatic endometriosis: a critical analysis of the evidence. Fertil Steril68,393\u2013401.","DOI":"10.1016\/S0015-0282(97)00193-3"},{"key":"key\n\t\t\t\t20171012082621_VERCELLINI-ET-AL-2003A","doi-asserted-by":"crossref","unstructured":"Vercellini P , Fedele L, Pietropaolo G, Frontino G, Somigliana E and Crosignani PG (2003) Progestogens for endometriosis: forward to the past. Hum Reprod Update9,387\u2013396.","DOI":"10.1093\/humupd\/dmg030"},{"key":"key\n\t\t\t\t20171012082621_VERCELLINI-ET-AL-2003B","doi-asserted-by":"crossref","unstructured":"Vercellini P , Frontino G, De Giorgi O, Pietropaolo G, Pasin R and Crosignani PG (2003) Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen. Fertil Steril80,560\u2013563.","DOI":"10.1016\/S0015-0282(03)00794-5"},{"key":"key\n\t\t\t\t20171012082621_VIGANO-2003","unstructured":"Vigan\u00f2 P , Mangioni S, Odorizzi MP, Chiodini A, Rocca S and Chiodo I (2003) Use of estrogen antagonists and aromatase inhibitors in endometriosis. Curr Opin Invest Drugs4,1209\u20131212."},{"key":"key\n\t\t\t\t20171012082621_WESTHOFF-2003","doi-asserted-by":"crossref","unstructured":"Westhoff C (2003) Depot-medroxyprogesterone acetate injection (Depo-Provera\u00ae): a highly effective contraceptive option with proven long-term safety. Contraception68,75\u201387.","DOI":"10.1016\/S0010-7824(03)00136-7"},{"key":"key\n\t\t\t\t20171012082621_WHEELER-1989","unstructured":"Wheeler JM (1989) Epidemiology of endometriosis-associated infertility. J Reprod Med34,41\u201346."},{"key":"key\n\t\t\t\t20171012082621_WHOCSCDSHC-1997","doi-asserted-by":"crossref","unstructured":"WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception (1997) Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. Lancet349,1202\u20131209.","DOI":"10.1016\/S0140-6736(97)02358-1"},{"key":"key\n\t\t\t\t20171012082621_WINKEL-2000","doi-asserted-by":"crossref","unstructured":"Winkel CA (2000) A cost-effective approach to the management of endometriosis. Curr Opin Obstet Gynecol12,317\u2013320.","DOI":"10.1097\/00001703-200008000-00009"},{"key":"key\n\t\t\t\t20171012082621_WINKEL-2003","unstructured":"Winkel CA (2003) Evaluation and management of women with endometriosis. Obstet Gynecol102,397\u2013408"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/21\/1\/248\/1527649\/dei290.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T20:39:31Z","timestamp":1586464771000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/humrep\/article\/21\/1\/248\/570670\/Subcutaneous-depot-medroxyprogesterone-acetate"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,21]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,9,21]]},"published-print":{"date-parts":[[2006,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/dei290","relation":{},"ISSN":["1460-2350","0268-1161"],"issn-type":[{"value":"1460-2350","type":"electronic"},{"value":"0268-1161","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,1]]},"published":{"date-parts":[[2005,9,21]]}}}